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Abstract
Background: Differences in sex hormone levels among populations might contribute to the variation in breast
cancer incidence across countries. Previous studies have shown higher breast cancer incidence and mortality
among Japanese Brazilians than among Japanese. To clarify the difference in hormone levels among populations,
we compared postmenopausal endogenous sex hormone levels among Japanese living in Japan, Japanese
Brazilians living in the state of São Paulo, and non-Japanese Brazilians living in the state of São Paulo.
Methods: A cross-sectional study was conducted using a control group of case-control studies in Nagano,
Japan, and São Paulo, Brazil. Participants were postmenopausal women older than 55 years of age who
provided blood samples. We measured estradiol, estrone, androstenedione, dehydroepiandrosterone sulfate
(DHEAS), testosterone and free testosterone by radioimmunoassay; bioavailable estradiol by the ammonium
sulfate precipitation method; and sex hormone-binding globulin (SHBG) by immunoradiometric assay. A total
of 363 women were included for the present analyses, comprising 185 Japanese, 44 Japanese Brazilians and
134 non-Japanese Brazilians.
Results: Japanese Brazilians had significantly higher levels of estradiol, bioavailable estradiol, estrone, testosterone
and free testosterone levels, and lower SHBG levels, than Japanese. Japanese Brazilians also had significantly higher
levels of bioavailable estradiol, estrone and DHEAS and lower levels of SHBG and androstenedione than non-
Japanese Brazilians. Levels of estradiol, testosterone and free testosterone, however, did not differ between
Japanese Brazilians and non-Japanese Brazilians. These differences were observed even after adjustment for known
breast cancer risk factors. We also found an increase in estrogen and androgen levels with increasing body mass
index, but no association for most of the other known risk factors.
Conclusions: We found higher levels of estrogens and androgens in Japanese Brazilians than in Japanese and
levels similar to or higher than in non-Japanese Brazilians. Our findings may help explain the increase in the
incidence and mortality rate of breast cancer among Japanese Brazilians.
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The incidence and mortality rate of breast cancer vary
considerably across countries and regions [1]. Although
Japan has a lower risk for female breast cancer than
Western countries, the incidence has gradually increased
over the past 30 years [2,3]. The incidence and mortality
rates in Japanese immigrants living in the United States
and Brazil have approximated those in the host country
[4-8]. For example, the mortality rate of first-generation
Japanese immigrants to São Paulo, Brazil, increased
from 1979 to 2001, with rates being intermediate
between Japanese living in Japan and Brazilians living in
the state of São Paulo [6].
Many epidemiologic studies have indicated that endo-
genous sex hormones, particularly estrogens, play an
important role in the etiology of breast cancer [9]. A
pooled analysis of nine prospective studies showed that
higher estrogens and their androgen precursors were
associated with a higher risk of breast cancer in postme-
nopausal women [9]. Differences in sex hormone levels
among populations might therefore contribute to the
variation in breast cancer incidence across countries and
regions. Clarification of the difference in sex hormone
levels among populations and their determinants might
help our understanding of the etiology and prevention
of breast cancer.
A relatively large number of epidemiological studies
have examined sex hormone levels among ethnic groups
and factors associated with sex hormone levels [10-16].
To our knowledge, however, no study has investigated
sex hormone levels among Japanese Brazilians. In addi-
tion, although previous studies consistently showed that
body weight and obesity were associated with higher
estrogen levels in postmenopausal women [10-12,15],
findings regarding other factors that influence circulating
sex hormone levels have been inconsistent [10-14,16].
We have conducted a cross-sectional study using a
control group of case-control studies in Nagano, Japan,
and São Paulo, Brazil. The present study compared post-
menopausal endogenous sex hormone levels among
Japanese living in Japan, Japanese Brazilians living in
São Paulo and non-Japanese Brazilians living in São
Paulo, and examined factors associated with these levels.
Methods
Study participants
Participants were postmenopausal women who were
enrolled as controls in multicenter, hospital-based, case-
control studies of breast cancer. In addition to determin-
ing lifestyle factors and genetic susceptibility to the risk
of breast cancer, the protocols of these studies were also
designed to compare potential risk factors among Japa-
nese living in Nagano, Japan, and Japanese Brazilians and
non-Japanese Brazilians living in the state of São Paulo,
Brazil. Details of this study have been described pre-
viously [17]. The study protocol was approved by Comis-
são Nacional de Ética em Pesquisa, Brasília, Brazil, and
by the institutional review board of the National Cancer
Center, Tokyo, Japan.
Briefly, eligible cases were a consecutive series of
female patients ages 20 to 74 years with newly diag-
nosed and histologically confirmed invasive breast can-
cer. Inhabitants of the state of São Paulo were recruited
and asked their ethnicity. Japanese and their descen-
dants were defined as Japanese Brazilians, and Cauca-
sian, black and mixed ethnicity populations were
defined as non-Japanese Brazilians. A total of 405 indivi-
duals (98%) participated in Nagano, and 83 Japanese
Brazilians (91%) and 389 non-Japanese Brazilians (99%)
participated in São Paulo. In the study in Nagano, eligi-
ble controls were selected from among medical checkup
examinees in two of the four hospitals and were con-
firmed not to have cancer. One control was matched for
each case by age (within 3 years) and by residential area.
Among potential controls, one examinee refused to par-
ticipate and two refused to provide blood samples. In
the study in São Paulo, eligible controls were preferen-
tially selected from among cancer-free patients who vis-
ited the same hospital as the index cases. One control
was matched for each case by age (within 5 years) and
by ethnicity. Among potential controls, 22 patients
refused to participate (participation rate, 96%). Conse-
quently, we obtained written, informed consent from a
total of 877 matched pairs (405 for Japanese, 83 for
Japanese Brazilians and 389 for non-Japanese Brazilians).
Of 877 controls, we selected postmenopausal women
over 55 years of age who provided blood samples and
reported an energy intake between 500 and 4,000 kcal.
Menopausal status was determined by self-report, and
energy intake was assessed using a food frequency ques-
tionnaire (FFQ). The present study included a total of
382 women comprising 185 Japanese, 46 Japanese Brazi-
lians and 151 non-Japanese Brazilians.
Data collection
Participants in Nagano were asked to complete a self-
administered questionnaire, while in-person interviews
were conducted in São Paulo by trained interviewers
using a structured questionnaire. The two question-
naires contained closely similar questions concerning
demographic characteristics, medical history, family his-
tory of cancer, menstrual and reproductive history,
anthropometric factors, physical activity, smoking habits
and dietary factors assessed by FFQ.
Participants in Nagano provided blood samples at the
time they returned their self-administered questionnaire,
and those in São Paulo provided blood samples at the
time of the interview. Blood samples were divided into
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buffy coat layers in São Paulo. All blood samples were
shipped to the Epidemiology and Prevention Division,
Research Center for Cancer Prevention and Screening,
National Cancer Center, Tokyo, Japan, and stored at
-80°C until analysis.
Laboratory analysis
We used a radioimmunoassay method to measure estra-
diol, estrone, androstenedione, dehydroepiandrosterone
sulfate (DHEAS), testosterone and free testosterone in
serum for the Nagano participants and in plasma for the
São Paulo participants. The following kits were used:
estradiol (DSL-4800 Ultra-Sensitive Estradiol Radioim-
munoassay Kit; Diagnostic System Laboratories, Inc.,
Webster, TX, USA), estrone (DSL-8700 Estrone Radio-
immunoassay Kit; Diagnostic System Laboratories, Inc.),
androstenedione (DPC · Androstenedione; Diagnostic
Products Corporation, Llanberis, UK), DHEAS (DPC ·
DHEA-S Kit, Diagnostic Products Corporation), testos-
terone (DPC · Testosterone Kit; Diagnostic Products
Corporation) and free testosterone (DPC · Free Testos-
terone Kit; Diagnostic Products Corporation). Bioavail-
able estradiol (free and albumin-bound estradiol) was
measured using the ammonium sulfate precipitation
method. Sex hormone-binding globulin (SHBG) was
measured by immunoradiometric assay (IRMA) using
Spectria SHBG IRMA (Orion Diagnostica, Espoo, Fin-
land). The kit for estrone was applicable to serum sam-
ples only, although other kits or methods were
applicable to both serum and plasma samples. We
therefore measured estrone levels in both serum and
plasma from the same women over 50 years of age (n =
38) and calibrated estrone levels in plasma on the basis
of a regression function, although the two levels were
highly correlated (correlation coefficient = 0.94) and the
percentage difference was relatively small (mean = -4%;
95% confidence interval, -9% to 1%). Lower detection
limits (LODs) were 5 pg/mL for estradiol, 15 pg/mL for
estrone, 6.25 nM/L for SHBG, 0.1 ng/mL for androste-
nedione, 5 μg/dL for DHEAS, 0.05 ng/mL for testoster-
one and 0.4 pg/mL for free testosterone. Measurement
values below the LOD were assigned half the value of
the LOD if measurable values below the LOD were not
available. The intra-assay coefficients of variation were
6.5% for estradiol at a mean concentration of 24.9 pg/
mL (n = 12), 10.6% for bioavailable estradiol at a mean
concentration of 48.1% (n = 10), 5.6% for estrone at a
mean concentration of 101.7 pg/mL (n =1 0 ) ,4 . 7 %f o r
SHBG at a mean concentration of 104.6 nM/L (n =1 0 ) ,
9.4% for androstenedione at a mean concentration of
1.33 ng/mL (n = 10), 5.2% for DHEAS at a mean con-
centration of 75 μg/dL (n = 10), 4.5% for testosterone at
a mean concentration of 0.83 ng/mL (n = 10) and 11.6%
for free testosterone at a mean concentration of 5.4 pg/
mL (n = 10). Interassay coefficients of variation were
9.7% for estradiol at a mean concentration of 28.0 pg/
mL (n = 8), 11.9% for bioavailable estradiol at a mean
concentration of 52.3% (n = 9), 11.1% for estrone at a
mean concentration of 90.1 pg/mL (n = 8), 5.5% for
SHBG at a mean concentration of 124.0 nM/L (n =1 0 ) ,
9.8% for androstenedione at a mean concentration of
1.10 ng/mL (n = 20), 5.3% for DHEAS at a mean con-
centration of 92.5 μg/dL (n = 20), 7.7% for testosterone
at a mean concentration of 0.90 ng/mL (n = 20) and
9.0% for free testosterone at a mean concentration of
6.4 pg/mL (n = 10). All hormone assays were performed
by a commercial laboratory( M i t s u b i s h iK a g a k uB i o -
Clinical Laboratories, Tokyo, Japan).
Statistical analysis
We excluded a total of 19 participants with estrone
values >125 pg/mL, estradiolv a l u e s> 7 5p g / m Lo rt e s -
tosterone values >125 ng/dL (indicating postmenopausal
hormone use), leaving 185 Japanese, 44 Japanese Brazi-
lians and 134 non-Japanese Brazilians for inclusion in
the present analyses.
All hormone values were natural log-transformed to
produce approximately normal distributions. Geometric
mean hormone levels according to the three popula-
tions, known breast cancer risk factors and lifestyle fac-
tors were calculated using multivariate regression
analysis. The following variables were used for adjust-
ment: age, ethnic group, age at first menarche, age at
menopause, number of births, age at first birth, height,
body mass index (BMI), smoking status, alcohol drink-
ing habits and physical activity during the past 5 years.
Analysis of covariance was used to test for differences in
mean hormone levels across the three populations,
known breast cancer risk factors and lifestyle factors.
For comparisons among the three populations, Japanese
Brazilians living in São Paulo were used as the reference
group. Linear trends for mean hormone levels were
tested in the multivariate regression model using cate-
gories of each factor as ordinal or continuous variables.
All P values reported are two-sided, and the statistical
significance level was set at P < 0.05. All statistical ana-
lyses were performed using SAS software version 9.1
(SAS Institute, Inc., Cary, NC, USA).
Results
The characteristics of the study populations are pre-
sented in Table 1. Japanese participants had a later
menarche, fewer births and lower BMI, and they
smoked less, drank more and were physically more
active than the other two populations. On the other
hand, non-Japanese Brazilians had earlier ages at meno-
pause and at first birth, more births and greater BMI,
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less active than the other two populations. Japanese Bra-
zilians had an earlier menarche, more births and greater
BMI, and they smoked more, drank less and were physi-
cally less active than Japanese, but they had later ages at
menopause and first birth, fewer births and lower BMI,
and they smoked less and were shorter and physically
more active than non-Japanese Brazilians.
Because of an insufficient amount of sampled blood,
we did not measure the levels of the following hor-
mones: estradiol for 17 participants; bioavailable estra-
diol, estrone or SHBG for two participants each; or
androstenedione for one participant. The proportion of
participants with levels below the LOD were 0.9% for
estradiol, 3.6% for estrone, 0% for bioavailable estradiol
and SHBG, 0.6% for androstenedione and DHEAS, 24%
for testosterone and 69% for free testosterone.
Adjusted hormone levels varied significantly across the
three populations for all hormones (Table 2). Japanese
Brazilians had significantly higher levels of estradiol,
bioavailable estradiol, estrone, testosterone and free tes-
tosterone, and lower SHBG levels, than Japanese,
whereas levels of androstenedione and DHEAS did not
differ between the two populations (Table 2). Similar
results were seen for analyses stratified by BMI (under
and over 25), except for androstenedione level, which
did not differ between Japanese Brazilians and Japanese
whose BMI was under 25, but androstenedione level
was significantly lower among Japanese Brazilians than
among Japanese whose BMI was over 25 (Table 3).
Table 1 Characteristics of study populations
Japanese living in
Nagano, Japan
Japanese Brazilians living in
São Paulo, Brazil
Non-Japanese Brazilians living in
São Paulo, Brazil
P for
difference
Number of participants 185 44 134
Mean age (±SE), yr 62.8 (0.40) 63.8 (0.82) 63.6 (0.47) 0.37
P
a 0.31 Reference 0.84
Family history of breast cancer, n
(%)
17 (9.2) 5 (11.4) 14 (10.5) 0.92
P
a 0.68 Reference 0.98
History of benign breast disease,
n (%)
11 (6.0) 4 (9.1) 8 (6.0) 0.46
P
a 0.65 Reference 0.62
Mean age at first menarche (±SE),
yr
13.9 (0.12) 13.2 (0.26) 13.3 (0.15) <0.01
P
a <0.01 Reference 0.75
Mean age at menopause (±SE), yr 50.0 (0.34) 50.8 (0.69) 48.2 (0.40) <0.01
P
a 0.29 Reference <0.01
Nulliparous, n (%) 17 (9.2) 5 (11.4) 15 (11.2) 0.55
P
a 0.58 Reference 0.81
Number of births (more than four
births), n (%)
b
6 (3.6) 12 (30.8) 57 (47.9) <0.01
P
a <0.01 Reference <0.01
Mean age at first birth (±SE), yr
b 26.2 (0.34) 26.5 (0.72) 23.6 (0.41) <0.01
P
a 0.65 Reference <0.01
Breast feeding (yes), n (%)
b 154 (93.3) 35 (89.7) 107 (89.9) 0.72
P
a 0.27 Reference 0.61
Mean height (±SE), cm 152.9 (0.43) 151.8 (0.89) 157.1 (0.52) <0.01
P
a 0.29 Reference <0.01
Mean body mass index (±SE), kg/
m
2
23.4 (0.28) 24.7 (0.57) 27.0 (0.34) <0.01
P
a 0.04 Reference <0.01
Smoking (ever smoker), n (%) 6 (3.3) 7 (15.9) 38 (28.4) <0.01
P
a <0.01 Reference <0.01
Alcohol drinking (drinker), n (%) 67 (36.2) 5 (11.4) 25 (18.7) <0.01
P
a <0.01 Reference 0.63
Physical activity in past 5 years
(yes), n (%)
85 (46.5) 19 (43.2) 26 (19.4) <0.01
P
a <0.01 Reference <0.01
aP values for comparison with Japanese Brazilians living in São Paulo, Brazil;
bAmong parous women only.
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a
Japanese living in
Nagano, Japan
Japanese Brazilians living in São
Paulo, Brazil
Non-Japanese Brazilians living in
São Paulo, Brazil
P for
difference
Estradiol, pg/mL
Age-adjusted 9.0 13.8 15.5 <0.01
(95% CI) (8.6 to 9.4) (12.5 to 15.3) (14.6 to 16.5)
P
a <0.01 Reference 0.052
Multivariate
b 9.7 14.3 15.5 <0.01
(95% CI) (8.7 to 10.9) (12.5 to 16.4) (14.0 to 17.1)
P
a <0.01 Reference 0.28
Bioavailable estradiol, %
Age-adjusted 23.1 30.6 22.9 <0.01
(95% CI) (22.1 to 24.1) (28.0 to 33.4) (21.7 to 24.1)
P
a <0.01 Reference <0.01
Multivariate
b 23.7 30.2 20.6 <0.01
(95% CI) (21.6 to 26.0) (27.0 to 33.8) (19.0 to 22.3)
P
a <0.01 Reference <0.01
Estrone, pg/mL
Age-adjusted 23.0 40.3 34.1 <0.01
(95% CI) (22.0 to 24.0) (36.8 to 44.1) (32.4 to 35.9)
P
a <0.01 Reference <0.01
Multivariate
b 23.8 41.1 33.3 <0.01
(95% CI) (21.5 to 26.3) (36.5 to 46.3) (30.6 to 36.4)
P
a <0.01 Reference <0.01
Sex hormone-binding
globulin, nM/L
Age-adjusted 74.1 54.3 60.2 <0.01
(95% CI) (69.4 to 79.1) (47.5 to 62.0) (55.8 to 65.1)
P
a <0.01 Reference 0.18
Multivariate
b 68.4 53.0 70.7 0.01
(95% CI) (59.5 to 78.5) (44.9 to 62.4) (62.6 to 79.7)
P
a <0.01 Reference <0.01
Androstenedione, ng/mL
Age-adjusted 0.65 0.56 1.04 <0.01
(95% CI) (0.60 to 0.70) (0.47 to 0.66) (0.95 to 1.15)
P
a 0.12 Reference <0.01
Multivariate
b 0.73 0.60 1.00 <0.01
(95% CI) (0.61 to 0.88) (0.48 to 0.76) (0.85 to 1.18)
P
a 0.06 Reference <0.01
DHEAS, μg/dL
Age-adjusted 50.6 58.0 44.5 0.03
(95% CI) (46.3 to 55.4) (48.2 to 69.8) (40.0 to 49.4)
P
a 0.19 Reference 0.01
Multivariate
b 57.2 63.1 46.7 0.04
(95% CI) (46.6 to 70.2) (49.4 to 80.6) (39.2 to 55.8)
P
a 0.38 Reference 0.02
Testosterone, ng/mL
Age-adjusted 0.02 0.11 0.18 <0.01
(95% CI) (0.02 to 0.03) (0.07 to 0.17) (0.14 to 0.24)
P
a <0.01 Reference 0.06
Multivariate
b 0.03 0.10 0.14 <0.01
(95% CI) (0.02 to 0.04) (0.06 to 0.20) (0.09 to 0.22)
P
a <0.01 Reference 0.38
Free testosterone, pg/mL
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bioavailable estradiol, estrone and DHEAS, and lower
levels of SHBG and androstenedione, than non-Japanese
Brazilians. Levels of estradiol, testosterone and free tes-
tosterone, however, did not differ between Japanese Bra-
zilians and non-Japanese Brazilians (Table 2). Similar
results were obtained when analyses were stratified by
BMI (under and over 25), except for estrone and
DHEAS. Levels of estrone were significantly higher
among Japanese Brazilians than among non-Japanese
Brazilians in individuals with a BMI under 25, but
estrone levels did not differ between the two popula-
tions in individuals whose BMI was over 25, while
DHEAS level did not differ regardless of BMI (under or
over 25) (Table 3).
We further examined associations between endogenous
sex hormone levels and known breast cancer risk factors
or lifestyle factors (Table 4). BMI was significantly asso-
ciated with higher estradiol, bioavailable estradiol,
estrone, androstenedione, testosterone and free testoster-
one levels, as well as lower SHBG levels, but was not
associated with DHEAS levels. Stratified analyses by
s t u d ys i t e( t h a ti s ,t h es t u d yi nN a g a n ov s .t h es t u d yi n
São Paulo) showed similar results for the two study sites.
No statistically significant associations were observed
between sex hormone levels and family history of breast
cancer, history of benign breast disease, age at first
menarche, age at menopause, parity, number of births,
age at first birth, breast-feeding, height, smoking, alcohol
drinking or physical activity during the past 5 years
except for the following. We found a significantly higher
level of SHBG among women who had a later age at
menopause and among shorter women. We also observed
a significantly higher level of DHEAS among women who
had more births and a significantly lower level of testos-
terone among physically more active women. In stratified
analyses by study site, however, we did not observe any
findings which were consistent between the sites.
Discussion
In this cross-sectional study among postmenopausal
Japanese, Japanese Brazilian and non-Japanese Brazilian
women, we found significant differences in endogenous
sex hormones among the three populations even after
adjustment for known breast cancer risk factors. In par-
ticular, levels of estrogen and androgen in Japanese Bra-
zilians were higher than levels in Japanese and were
similar to or higher than levels in non-Japanese Brazi-
lians. This pattern was observed for women with BMI
values under and over 25. We also confirmed an
increase in estrogen and androgen levels and a decrease
in SHBG levels with increasing BMI.
As an initial comment, several methodological limita-
tions of this study should be considered. First, our find-
ings might be subject to the difference in study methods
between Japan and Brazil, albeit that the two studies
were conducted under a similar protocol. For example,
we used serum samples for Japanese and plasma sam-
ples for both Japanese Brazilians and non-Japanese Bra-
zilians. In this regard, we measured estrone levels in
both serum and plasma from the same participants (n =
38). Although both levels were highly correlated (corre-
lation coefficient = 0.94) and the percentage difference
was relatively small (mean = -4%; 95% confidence inter-
val, -9% to 1%), we used corrected values for the present
study because the kit for estrone was applicable to
serum samples only. Concurrently, we compared estrone
levels among the three populations using crude values
and observed the same results .T h ed i f f e r e n c ei nb l o o d
samples is therefore unlikely to have affected the differ-
ence in sex hormone levels between the two popula-
tions. Given that blood collection methods also differed
between the Japan and Brazil study sites, in addition to
the types of blood samples used, we cannot exclude the
possibility that our findings were affected by these dif-
ferences. Another example is the difference in question-
naire data and data collection methods between Japan
and Brazil. If such differences led to exposure misclassi-
fication, this might explain the observed absence of
associations between sex hormone levels and known
breast cancer risk factors or lifestyle factors. Second,
although at least more than 96% of participants
had detectable levels of estradiol, estrone, bioavailable
estradiol, SHBG, androstenedione and DHEAS, the
Table 2 Adjusted geometric mean hormone levels in three populations
a (Continued)
Age-adjusted 0.21 0.39 0.44 <0.01
(95% CI) (0.19 to 0.23) (0.33 to 0.46) (0.40 to 0.48)
P
a <0.01 Reference 0.18
Multivariate
b 0.22 0.39 0.39 <0.01
(95% CI) (0.19 to 0.26) (0.32 to 0.47) (0.34 to 0.45)
P
a <0.01 Reference 0.92
DHEAS, dehyroepianrosterone sulfate; 95% CI, 95% confidence interval;
aP values for comparison with Japanese Brazilians living in São Paulo, Brazil;
bAdjusted for
age (continuous), age at first menarche (continuous), age at menopause (continuous), number of births (0, 1, 2 or 3, 4+), age at first birth (≤22, 23 to 26, ≥27 yr,
nulliparous), height (continuous), body mass index (continuous), smoking (never smokers, past smokers, current smokers), alcohol drinking (nondrinkers,
occasional drinker, regular drinkers), and physical activity in past 5 years (no, ≤2 days/wk, ≥3 days/wk).
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was relatively high for testosterone (24%) and free tes-
tosterone (69%). Our findings for testosterone and free
testosterone should thereforeb ei n t e r p r e t e dc a u t i o u s l y .
T h i r d ,s i n c eo u rs t u d yi n c l u d e do n l yas m a l ln u m b e ro f
Japanese Brazilians (n = 44), the findings might be due
to chance and should be interpreted with caution.
We found higher circulating levels of estrogen and
androgen in Japanese Brazilians than in Japanese, which
were not accounted for by differences in the prevalence
Table 3 Adjusted geometric mean hormone levels
a of three populations with stratification by body mass index
b
Japanese living in
Nagano, Japan
Japanese Brazilians living in São
Paulo, Brazil
Non-Japanese Brazilians living in
São Paulo, Brazil
P for
difference
Estradiol, pg/mL
Low (BMI < 25) 9.5 14.2 15.0 <0.01
P
c <0.01 Reference 0.60
High (BMI ≥25) 8.2 12.2 14.5 <0.01
P
c <0.01 Reference 0.06
Bioavailable estradiol, %
Low (BMI <25) 22.4 28.7 17.9 <0.01
P
c <0.01 Reference <0.01
High (BMI ≥ 25) 25.6 32.5 23.4 <0.01
P
c <0.01 Reference <0.01
Estrone, pg/mL
Low (BMI < 25) 22.5 40.4 32.1 <0.01
P
c <0.01 Reference <0.01
High (BMI ≥25) 23.2 38.4 34.2 <0.01
P
c <0.01 Reference 0.19
Sex hormone-binding
globulin, nM/L
Low (BMI < 25) 76.6 62.8 85.8 0.03
P
c 0.04 Reference <0.01
High (BMI ≥25) 59.6 43.8 59.5 0.03
P
c 0.02 Reference 0.02
Androstenedione, ng/mL
Low (BMI < 25) 0.64 0.63 0.91 0.03
P
c 0.90 Reference 0.02
High (BMI ≥25) 0.76 0.51 1.05 <0.01
P
c 0.03 Reference <0.01
DHEAS, μg/dL
Low (BMI < 25) 51.9 64.7 48.7 0.21
P
c 0.13 Reference 0.11
High (BMI ≥25) 54.6 52.2 43.4 0.29
P
c 0.81 Reference 0.32
Testosterone, ng/mL
Low (BMI < 25) 0.01 0.07 0.13 <0.01
P
c <0.01 Reference 0.27
High (BMI ≥25) 0.04 0.15 0.18 <0.01
P
c <0.01 Reference 0.69
Free testosterone, pg/mL
Low (BMI < 25) 0.18 0.32 0.31 <0.01
P
c <0.01 Reference 0.90
High (BMI ≥25) 0.26 0.46 0.48 <0.01
P
c <0.01 Reference 0.85
BMI, body mass index; DHEAS, dehyroepianrosterone sulfate;
aAdjusted for age (continuous), age at first menarche (continuous), age at menopause (continuous),
number of births (0, 1, 2 or 3, 4+), age at first birth (≤22, 23 to 26, ≥27, nulliparous), height (continuous), BMI (continuous), smoking (never smokers, past
smokers, current smokers), alcohol drinking (nondrinkers, occasional drinkers, regular drinkers) and physical activity in the past 5 years (no, ≤2 days/wk, ≥3 days/
wk);
bThe total participants in the low and high BMI groups were 199 and 156, respectively;
cP values for comparison with Japanese Brazilians living in São Paulo,
Brazil.
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Page 7 of 11Table 4 Adjusted geometric mean hormone levels by breast cancer risk factors and lifestyle-factors
a
Breast cancer
risk and
lifestyle
factors
Participants,
n
Estradiol,
pg/mL
Bioavailable
estradiol, %
Estrone,
pg/mL
Sex
hormone-
binding
globulin,
nM/L
Androstenedione,
ng/mL
DHEAS,
μg/dL
Testosterone,
ng/mL
Free
testosterone,
pg/mL
Family history
of breast cancer
No 327 13.9 22.7 32.6 66.2 0.84 52.7 0.09 0.34
Yes 36 13.8 21.2 31.6 74.6 0.80 51.4 0.05 0.36
P for
difference
0.90 0.18 0.57 0.12 0.66 0.83 0.08 0.40
History of
benign breast
disease
No 339 13.9 22.6 32.5 66.9 0.84 52.9 0.09 0.34
Yes 23 14.3 22.0 33.5 69.0 0.78 52.1 0.08 0.31
P for
difference
0.69 0.68 0.67 0.75 0.61 0.92 0.72 0.38
Age at first
menarche, yr
<12 101 13.7 22.9 31.6 66.7 0.83 49.5 0.08 0.33
13 or 14 166 13.9 22.2 32.4 65.2 0.83 54.8 0.09 0.34
15+ 96 13.9 22.6 33.6 69.7 0.85 53.3 0.08 0.35
P for trend 0.81 0.81 0.18 0.51 0.78 0.43 0.99 0.60
P for
trend
b
0.70 0.47 0.30 0.24 0.68 0.29 0.83 0.39
Age at
menopause, yr
<48 116 14.0 23.0 32.6 64.5 0.89 57.0 0.08 0.34
49 to 51 108 14.0 22.0 33.1 70.2 0.78 51.6 0.09 0.34
52+ 139 13.6 22.5 32.1 67.0 0.80 48.5 0.09 0.33
P for trend 0.47 0.65 0.68 0.57 0.20 0.05 0.66 0.75
P for
trend
b
0.80 0.06 0.93 0.02 0.32 0.51 0.59 1.00
Parity
Parous 326 13.8 22.0 32.3 67.5 0.80 48.4 0.08 0.33
Nulliparous 37 13.7 23.3 32.9 67.2 0.87 58.0 0.10 0.34
P for
difference
0.89 0.28 0.73 0.95 0.42 0.11 0.51 0.86
Number of
births
c
1 32 13.7 20.6 32.8 69.6 0.77 43.7 0.10 0.30
2 or 3 219 13.4 22.2 31.6 67.8 0.79 43.9 0.08 0.32
4+ 75 14.7 22.3 33.2 65.8 0.86 56.0 0.08 0.35
P for trend 0.27 0.26 0.71 0.55 0.38 0.046 0.76 0.20
Age at first
birth
c,y r
<22 79 13.2 21.3 31.5 70.9 0.80 44.0 0.09 0.31
23 to 26.9 138 13.9 21.5 33.1 68.1 0.78 46.7 0.07 0.33
27+ 109 14.7 22.3 33.1 64.3 0.84 52.2 0.10 0.32
P for trend 0.09 0.29 0.52 0.16 0.47 0.11 0.40 0.89
P for
trend
b
0.10 0.32 0.53 0.37 0.58 0.39 0.47 0.81
Breast-feeding
c
No 27 14.3 23.2 33.5 63.4 0.82 46.9 0.09 0.33
Yes 296 13.7 21.9 32.2 67.6 0.81 47.2 0.08 0.32
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Page 8 of 11of known breast cancer risk factors. This hormonal pro-
file in Japanese Brazilians is consistent with the higher
incidence and mortality rate of breast cancer in this
population [4-6]. For instance, the age-adjusted inci-
dence per 100,000 population for breast cancer among
first-generation Japanese Brazilians from 1969 to 1978
was 24, while the incidences among Japanese from 1973
to 1977 were 12.7 in Osaka and 17.5 in Miyagi [4]. The
standard mortality ratio for breast cancer among first-
generation Japanese Brazilians from 1999 to 2001 on the
basis of age-specific rates for Japanese in 2000 was 139
[5].
We also found higher circulating levels of bioavailable
estradiol and estrone in Japanese Brazilians than in non-
Japanese Brazilians, although levels of estradiol, testos-
terone and free testosterone did not significantly differ
between the two populations. In the Multiethnic Cohort
Study, Japanese Americans had significantly higher
Table 4 Adjusted geometric mean hormone levels by breast cancer risk factors and lifestyle-factors
a (Continued)
P for
difference
0.59 0.33 0.53 0.47 0.87 0.96 0.85 0.87
Height, cm
<150.9 107 13.8 22.3 32.2 69.4 0.84 54.7 0.09 0.34
151 to
156.9
126 14.3 22.1 33.4 67.2 0.81 51.9 0.08 0.34
157+ 124 13.7 23.2 32.2 63.8 0.85 51.7 0.09 0.34
P for trend 0.83 0.31 0.99 0.16 0.91 0.54 0.71 0.86
P for
trend
b
0.62 0.07 0.65 0.01 0.33 0.96 0.47 0.72
BMI, kg/m
2
<24.9 199 13.3 20.9 31.1 75.3 0.77 51.1 0.07 0.30
25 to 29.9 116 14.5 24.2 32.2 60.2 0.79 48.4 0.09 0.34
30+ 40 15.5 26.4 38.4 51.2 1.15 65.3 0.16 0.50
P for trend 0.01 <0.01 <0.01 <0.01 0.01 0.21 0.01 <0.01
P for
trend
b
<0.01 <0.01 <0.01 <0.01 <0.01 0.13 0.01 <0.01
Smoking
Never
smoker
310 13.2 24.3 32.0 62.9 0.80 53.5 0.09 0.35
Past
smoker
37 13.6 23.7 32.4 62.3 0.77 51.4 0.06 0.38
Current
smoker
14 14.9 20.0 33.2 76.3 0.94 52.8 0.12 0.29
P for
difference
0.48 0.06 0.91 0.28 0.55 0.95 0.43 0.28
Alcohol
drinking
Nondrinker 266 14.0 22.0 32.7 69.9 0.85 49.4 0.10 0.34
Occasional
drinker
39 14.1 23.5 32.4 63.7 0.82 59.1 0.08 0.34
Regular
drinker
58 13.5 22.2 32.4 67.1 0.83 49.8 0.08 0.34
P for
difference
0.76 0.48 0.97 0.42 0.89 0.29 0.48 0.98
Physical activity
in past 5 years
No 231 14.0 22.5 32.8 66.7 0.84 52.2 0.11 0.34
≤2 days/
wk
63 13.8 22.1 32.1 67.5 0.79 50.6 0.05 0.33
≥3 days/
wk
68 13.5 23.3 32.1 66.8 0.85 55.8 0.07 0.35
P for trend 0.46 0.48 0.58 0.95 0.97 0.56 0.02 0.60
DHEAS, dehyroepianrosterone sulfate; BMI, body mass index;
aAdjusted for age (continuous), ethnic group (Japanese, Japanese Brazilians, non-Japanese Brazilians
(Caucasian, mixed, Black), age at first menarche (continuous), age at menopause (continuous), number of births (0, 1, 2 or 3, 4+), age at first birth (≤22, 23 to 26,
≥27 yr, nulliparous), height (continuous), BMI (continuous), smoking (never smokers, past smokers, current smokers), alcohol drinking (nondrinkers, occasional
drinkers, regular drinkers) and physical activity in the past 5 years (no, ≤2 days/wk, ≥3 days/wk);
bContinuous variables;
cAmong parous women only.
Iwasaki et al. BMC Medicine 2011, 9:16
http://www.biomedcentral.com/1741-7015/9/16
Page 9 of 11estradiol levels than Caucasians and a slightly higher risk
factor-adjusted incidence of breast cancer [10,18].
Although previous studies have shown lower incidence
and mortality rates of breast cancer among Japanese Bra-
zilians than among non-Japanese Brazilians [4-6], our
findings suggest that the recent incidence and mortality
rates among Japanese Brazilians might be similar to or
higher than those of non-Japanese Brazilians.
T h es i g n i f i c a n td i f f e r e n c ei ns e xh o r m o n el e v e l s
between Japanese Brazilians and Japanese might be
determined by long-term exposure to environmental
and lifestyle factors in Brazil. These differences were
observed even after adjustment for known breast cancer
risk factors, including BMI, which is a major determi-
nant of estrogen levels in postmenopausal women.
Although diet is one environmental factor that substan-
tially differs between Japan and Brazil, the present study
did not take into account dietary factors because we
used different FFQ in the case-control studies in Nagano
and São Paulo. Given that the report from the World
Cancer Research Fund and American Institute for Can-
cer Research in 2007 showed no convincing or probable
dietary risk factors for breast cancer [19], however, the
difference in sex hormone levels between the two popu-
lations might not be explained by dietary factors only.
We observed an increase in estrogen and androgen
levels and a decrease in SHBG levels with increasing
BMI. Our findings are in general agreement with those
of previous studies, and these associations have been
consistently observed among both Asian and Western
populations [10-13,15]. On the other hand, the deter-
minants of sex hormone levels in postmenopausal
women have not been firmly established, notwithstand-
ing a relatively large number of epidemiological studies
[10-14,16]. In the present study, we found a higher
level of SHBG among women who had a later age at
menopause and among shorter women. We also
observed a higher level of DHEAS among women who
had more births and a lower level of testosterone
among physically more active women. In addition to
the lack of consistency in these findings between the
two study sites (that is, the study in Nagano vs. the
study in São Paulo), our findings are inconsistent with
those of previous studies, which found no significant
associations among age at menopause, height and
SHBG level, for example, or number of births and
DHEAS level [12-14]. Higher physical activity levels
were associated with lower levels of both estrogen and
androgen [11,16], while another study reported no
such association [10]. Given this lack of consistency
with previous studies, our findings might be explained
by multiple comparisons.
Conclusions
We found that levels of estrogen and androgen in Japa-
nese Brazilians were higher than those in Japanese and
similar to or higher than levels in non-Japanese Brazi-
lians. Our findings may explain the previously observed
increase in the incidence and mortality rate of breast
cancer among Japanese Brazilians.
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